SOLIGENIX, INC. Subsequent Event, Amount (Deprecated 2013-01-31)
SOLIGENIX, INC. (SNGX) reported Subsequent Event, Amount (Deprecated 2013-01-31) of $600.00 thousand for the 1-month period ending 2012-07-31, per its 10-Q filed 2012-08-10.
Discontinued › Notes
us-gaap:SubsequentEventAmount · last filed 2012-08-10
- 2012-07-31: Subsequent Event, Amount (Deprecated 2013-01-31) 1 month $600.00K.
| Period end | Subsequent Event, Amount (Deprecated 2013-01-31) 1 month |
|---|---|
| 2012-07-31 | $600.00K 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |